IART Q3 2022 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$385M-0.4% YoY

Gross Profit

$237M61.5% margin

Operating Income

$65M16.9% margin

Net Income

$50M13.0% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

$68M

Free Cash Flow

$59M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.1B

Stockholders' Equity

$1.7B

Cash & Equivalents

$512M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$385M	$387M	-0.4%
Gross Profit	$237M	$242M	-2.3%
Operating Income	$65M	$56M	+15.3%
Net Income	$50M	$43M	+15.5%

Revenue Segments

Codman Specialty Surgical

$250M65%

Tissue Technologies

$135M35%

Geographic Segments

UNITED STATES

$282M73%

Asia Pacific

$43M11%

Europe

$38M10%

Rest Of World

$22M6%